Search results for the GEO ID: GSE19403
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM482060
GPL1261
spinal cord wild type at 15 days, biological replicate 1 ventrolateral spinal cord white matter, wild type at 15 days genotype: Wild type developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482061
GPL1261
spinal cord wild type at 15 days, biological replicate 2 ventrolateral spinal cord white matter, wild type at 15 days genotype: Wild type developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482062
GPL1261
spinal cord wild type at 15 days, biological replicate 3 ventrolateral spinal cord white matter, wild type at 15 days genotype: Wild type developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482063
GPL1261
spinal cord Olig2cre/DA-Cat at 15 days, biological replicate 1 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 15 days genotype: Olig2cre/DA-Cat developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482064
GPL1261
spinal cord Olig2cre/DA-Cat at 15 days, biological replicate 2 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 15 days genotype: Olig2cre/DA-Cat developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482065
GPL1261
spinal cord Olig2cre/DA-Cat at 15 days, biological replicate 3 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 15 days genotype: Olig2cre/DA-Cat developmental stage: Day 15 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482066
GPL1261
spinal cord wild type at 4 days, biological replicate 1 ventrolateral spinal cord white matter, wild type at 4 days genotype: Wild type developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482067
GPL1261
spinal cord wild type at 4 days, biological replicate 2 ventrolateral spinal cord white matter, wild type at 4 days genotype: Wild type developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482068
GPL1261
spinal cord wild type at 4 days, biological replicate 3 ventrolateral spinal cord white matter, wild type at 4 days genotype: Wild type developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482069
GPL1261
spinal cord Olig2cre/DA-Cat at 4 days, biological replicate 1 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 4 days genotype: Olig2cre/DA-Cat developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482070
GPL1261
spinal cord Olig2cre/DA-Cat at 4 days, biological replicate 2 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 4 days genotype: Olig2cre/DA-Cat developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
GSM482071
GPL1261
spinal cord Olig2cre/DA-Cat at 4 days, biological replicate 3 ventrolateral spinal cord white matter, Olig2cre/DA-Cat at 4 days genotype: Olig2cre/DA-Cat developmental stage: Day 4 ventrolateral spinal cord white matter was injected with 1% lysolecithin
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes